The study of efficacy of AT1 receptor blocker, olmesartan and calcium antagonists , azelnidipine combination therapy in patients with essential hypertension , diabetic or chronic kidney disease
Not Applicable
Recruiting
- Conditions
- Patient with essential hypertension, diabetic or chronic kidney disease
- Registration Number
- JPRN-UMIN000004750
- Lead Sponsor
- Kochi Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
SCr > 3.0mg/dl Patient has liver dysfunction. It is a developing patient within six months as for cardiac infarction or the apoplexy. Patient who has possibility of pregnancy or pregnancy. Patient while suckling. Patient who judged that doctor is improper
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change from baseline in BP (office blood pressure, home blood pressure) The proportion of patients achieving the BP goal provided by the guideline for the management of hypertension in Japan
- Secondary Outcome Measures
Name Time Method The change from baseline of protein in urine and eGFR